# Orthofuse

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/orthofuse

- Industry: Medical Devices & Equipment
- Headquarters: UK
- Website: www.orthofuse.co.uk
- Total disclosed funding: $3M
- Latest round: Seed (Feb 12, 2026)
- Investors on record: 3

## About

Orthofuse Ltd., based in the UK, specializes in developing advanced orthopedic solutions through 3D printing technology, creating precision-engineered implants that improve surgical outcomes for trauma and spinal conditions.Orthofuse Ltd. is dedicated to providing advanced orthopedic solutions through 3D printing technology. In February 2026, Orthofuse Ltd. raised GBP 2.2 million in seed funding led by individual investor, with participation from ACF investors, Cambridge Enterprise, Empirical Ventures and company's management. Orthofuse specializes in advanced orthopedic solutions, primarily focusing on implants designed to address the challenges of orthopedic trauma and spinal degeneration. The company's core offerings leverage 3D printing technology to create precision-engineered implants that enhance surgical outcomes by providing improved flexibility and ease of repositioning during complex procedures. These implants are developed to cater to the specific needs of orthopedic surgeons, facilitating their workflows and minimizing the risks associated with surgical interventions. Orthofuse's products are designed for use in a variety of clinical settings, serving a diverse client base that includes hospitals, surgical centers, and orthopedic specialists predominantly in North America and Europe. By integrating cutting-edge manufacturing techniques, Orthofuse aims to improve patient care and surgical efficiency in markets that demand high-quality orthopedic solutions.The revenue model for Orthofuse is structured around direct sales to healthcare institutions and orthopedic professionals, facilitating a B2B approach in their transactions. The company engages in the sale of their proprietary implants and systems, which are typically purchased by hospitals and surgical centers, ensuring that these critical products reach the end-users effectively. Transactions are conducted through purchase orders, with agreements outlining terms for delivery and usage of their advanced solutions. While specific pricing plans for individual products are not disclosed, the focus remains on providing high-value solutions that enhance surgical precision and patient outcomes. Orthofuse's revenue is driven by the ongoing demand for innovative orthopedic technologies that address the complexities faced by surgeons in the operating room.In February 2026, Orthofuse Ltd. raised GBP 2.2 million in Seed funding to support its product development initiatives. The company plans to launch new orthopedic implant products that integrate advanced 3D printing technologies, targeting market release in the upcoming year. Additionally, Orthofuse aims to expand its presence in North America and Europe, with specific strategies to enter new regional markets by mid-2027. The recently secured funding will provide the necessary resources for expanding product lines and enhancing operational capabilities.

## Funding rounds

- Seed, Feb 12, 2026, $3M — Cambridge Enterprise, ACF Investors, Empirical Ventures

## Investors

- Cambridge Enterprise — Seed
- ACF Investors (https://capitalatlas.ai/funds/acf-investors) — Seed
- Empirical Ventures (https://capitalatlas.ai/funds/empirical-ventures) — Seed